Literature DB >> 28439880

Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.

Fiorella D'Auria1, Francesco La Rocca1, Vittorio Simeon2, Teodora Statuto1, Giuseppe Pietrantuono3, Giovanni D'Arena3, Oreste Villani3, Giovanna Mansueto3, Antonio Traficante4, Pellegrino Musto5.   

Abstract

Entities:  

Keywords:  complete remission; free light chain; heavy/light chain; multiple myeloma

Mesh:

Substances:

Year:  2017        PMID: 28439880     DOI: 10.1111/bjh.14662

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients.

Authors:  M Michallet; C Chapuis-Cellier; T Dejoie; C Lombard; H Caillon; M Sobh; P Moreau; M Attal; H Avet-Loiseau
Journal:  Leukemia       Date:  2017-06-30       Impact factor: 11.528

2.  The clinical utility of serum free light chain and heavy/light chain assays in monitoring disease activity in patients with IgG myeloma after achieving a deep response.

Authors:  Kazuyuki Shimizu; Yoshikazu Kamiya; Junji Itoh; Jun Okada; Merrell Lim; Satoru Sugiyama
Journal:  Clin Case Rep       Date:  2017-11-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.